vs

Side-by-side financial comparison of First Foundation Inc. (FFWM) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $48.4M, roughly 1.7× First Foundation Inc.). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -97.9%, a 59.8% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -2.7%).

John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

FFWM vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.7× larger
PRCT
$83.1M
$48.4M
FFWM
Growing faster (revenue YoY)
FFWM
FFWM
+401.5% gap
FFWM
421.7%
20.2%
PRCT
Higher net margin
PRCT
PRCT
59.8% more per $
PRCT
-38.1%
-97.9%
FFWM
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-2.7%
FFWM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FFWM
FFWM
PRCT
PRCT
Revenue
$48.4M
$83.1M
Net Profit
$-8.0M
$-31.6M
Gross Margin
64.9%
Operating Margin
-97.5%
-4.1%
Net Margin
-97.9%
-38.1%
Revenue YoY
421.7%
20.2%
Net Profit YoY
43.0%
-27.9%
EPS (diluted)
$-0.09
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FFWM
FFWM
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$48.4M
$76.4M
Q3 25
$63.6M
$83.3M
Q2 25
$51.4M
$79.2M
Q1 25
$71.4M
$69.2M
Q4 24
$9.3M
$68.2M
Q3 24
$9.2M
$58.4M
Q2 24
$57.5M
$53.4M
Net Profit
FFWM
FFWM
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-8.0M
$-29.8M
Q3 25
$-146.3M
$-21.4M
Q2 25
$-7.7M
$-19.6M
Q1 25
$6.9M
$-24.7M
Q4 24
$-14.1M
$-18.9M
Q3 24
$-82.2M
$-21.0M
Q2 24
$3.1M
$-25.6M
Gross Margin
FFWM
FFWM
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
FFWM
FFWM
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-97.5%
-40.6%
Q3 25
-92.7%
-27.8%
Q2 25
-21.1%
-28.0%
Q1 25
8.8%
-39.7%
Q4 24
-247.7%
-28.9%
Q3 24
-1276.7%
-38.4%
Q2 24
4.6%
-50.3%
Net Margin
FFWM
FFWM
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-97.9%
-39.1%
Q3 25
-230.1%
-25.7%
Q2 25
-15.0%
-24.7%
Q1 25
9.7%
-35.8%
Q4 24
-152.2%
-27.6%
Q3 24
-896.9%
-35.9%
Q2 24
5.4%
-48.0%
EPS (diluted)
FFWM
FFWM
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.09
$-0.54
Q3 25
$-1.78
$-0.38
Q2 25
$-0.09
$-0.35
Q1 25
$0.08
$-0.45
Q4 24
$-0.24
$-0.34
Q3 24
$-1.23
$-0.40
Q2 24
$0.05
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FFWM
FFWM
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$1.6B
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$912.6M
$347.7M
Total Assets
$11.9B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FFWM
FFWM
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$1.6B
$286.5M
Q3 25
$1.7B
$294.3M
Q2 25
$1.1B
$302.7M
Q1 25
$1.0B
$316.2M
Q4 24
$1.0B
$333.7M
Q3 24
$1.1B
$196.8M
Q2 24
$1.4B
$214.1M
Total Debt
FFWM
FFWM
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
FFWM
FFWM
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$912.6M
$365.9M
Q3 25
$917.9M
$380.3M
Q2 25
$1.1B
$385.8M
Q1 25
$1.1B
$389.2M
Q4 24
$1.1B
$402.2M
Q3 24
$1.1B
$241.2M
Q2 24
$933.2M
$251.8M
Total Assets
FFWM
FFWM
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$11.9B
$508.1M
Q3 25
$11.9B
$511.5M
Q2 25
$11.6B
$513.1M
Q1 25
$12.6B
$519.4M
Q4 24
$12.6B
$534.0M
Q3 24
$13.4B
$374.1M
Q2 24
$13.7B
$374.4M
Debt / Equity
FFWM
FFWM
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FFWM
FFWM
PRCT
PRCT
Operating Cash FlowLast quarter
$-31.9M
Free Cash FlowOCF − Capex
$-35.2M
FCF MarginFCF / Revenue
-72.8%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-45.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FFWM
FFWM
PRCT
PRCT
Q1 26
Q4 25
$-31.9M
$-10.3M
Q3 25
$9.2M
$-6.6M
Q2 25
$-16.3M
$-15.0M
Q1 25
$-552.0K
$-17.0M
Q4 24
$-8.7M
$-32.4M
Q3 24
$14.2M
$-18.8M
Q2 24
$-9.1M
$-15.7M
Free Cash Flow
FFWM
FFWM
PRCT
PRCT
Q1 26
Q4 25
$-35.2M
$-12.2M
Q3 25
$8.6M
$-9.5M
Q2 25
$-16.7M
$-17.8M
Q1 25
$-2.5M
$-18.8M
Q4 24
$-11.4M
$-33.6M
Q3 24
$13.4M
$-19.0M
Q2 24
$-9.4M
$-16.8M
FCF Margin
FFWM
FFWM
PRCT
PRCT
Q1 26
Q4 25
-72.8%
-15.9%
Q3 25
13.5%
-11.4%
Q2 25
-32.4%
-22.5%
Q1 25
-3.5%
-27.2%
Q4 24
-123.5%
-49.2%
Q3 24
146.2%
-32.6%
Q2 24
-16.3%
-31.4%
Capex Intensity
FFWM
FFWM
PRCT
PRCT
Q1 26
Q4 25
6.9%
2.4%
Q3 25
1.0%
3.4%
Q2 25
0.8%
3.5%
Q1 25
2.8%
2.7%
Q4 24
29.4%
1.7%
Q3 24
9.0%
0.4%
Q2 24
0.4%
2.0%
Cash Conversion
FFWM
FFWM
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
-0.08×
Q4 24
Q3 24
Q2 24
-2.96×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FFWM
FFWM

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons